Interpath Global

Interpath is an Australian biotechnology company specializing in the development of regenerative joint health treatments for humans and animals. The company is best known for its proprietary, patented plant-derived ingredient, Epiitalis, which is a seed oil extract from Biota orientalis. Epiitalis is clinically recognized for its ability to stimulate chondrocyte proliferation and suppress inflammatory mediators such as Prostaglandin E2 and Interleukin-1 beta. Interpath commercializes its products under the 4CYTE and Sashas Blend brands, providing non-invasive alternatives to traditional pharmaceutical interventions for osteoarthritis and degenerative joint disease. With a strong emphasis on evidence-based medicine, the company conducts extensive clinical research in collaboration with academic institutions to validate the efficacy of its regenerative therapies. Interpath operates globally, serving the human, equine, and canine healthcare markets from its headquarters in Australia.